Dr. Meghan Thompson is currently working as a research scientist and medical writer in real-world evidence at Indivior, a global pharmaceutical company with medications for opioid use disorder and overdose reversal. She completed her PharmD and PhD in pharmaceutical sciences, concentrating on medicinal chemistry, at Virginia Commonwealth University. Dr. Thompson has experience with medical, scientific, and regulatory writing and is focused on reaching optimal patient, business, and public health outcomes by translating scientific data into high-quality deliverables directed at researchers, regulators, clinicians, patients, and other key stakeholders.